Redox control of senescence and age-related disease

Redox Biology

Volumn 11, Issue , 2017, Pages 91-102

  Chandrasekaran, Akshaya ^a   Idelchik, Maria del Pilar Sosa ^a   Melendez, J Andrés ^a  

^a SUNY POLYTECHNIC INSTITUTE   (United States)

Author keywords

Aging; Oxidative stress; Reactive oxygen species (ROS); Senescence; Senescence associated secretory phenotype (SASP)

Indexed keywords

CALCIUM ION; INTERLEUKIN 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MATRIX METALLOPROTEINASE; REACTIVE OXYGEN METABOLITE; SIRTUIN; SOMATOMEDIN; TRANSCRIPTION FACTOR FOXO;

AGE RELATED DISEASE; AGING; CELL AGING; CELL GROWTH; CELL INFILTRATION; CELL PROLIFERATION; CELL STRESS; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; DISEASE ASSOCIATION; DISEASES; DNA REPLICATION; HUMAN; MICROENVIRONMENT; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SENESCENCE; SENESCENCE ASSOCIATED SECRETORY PHENOTYPE; SIGNAL TRANSDUCTION; TELOMERE; GENETICS; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY;

AGING; CELLULAR SENESCENCE; HUMANS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84998893299     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2016.11.005     Document Type: Review

References (249)

1. [1] Kirkwood, T.B.L., Understanding the odd science of aging. Cell 120:4 (2005), 437–447.
2. [2] Ljubuncic, P., Reznick, A.Z., The evolutionary theories of aging revisited - a mini-review. Gerontology 55:2 (2009), 205–216.
3. [3] Jin, K., Modern biological theories of aging. Aging Dis. 1:2 (2010), 72–74.
4. [4] Lipsky, M.S., King, M., Biological Theories of Aging. Disease-a-Month, 61, 2015, Elsevier, 460–466.
5. [5] Peng, C., Wang, X., Chen, J., Jiao, R., Wang, L., Li, Y.M., et al. Biology of ageing and role of dietary antioxidants. Biomed. Res Int, 2014, 2014, 831841.
6. [6] Medawar, P.B., An unsolved problem of biology. Evol. Health Dis., 1952, 24.
7. [7] Williams, G.C., Pleiotropy, natural selection, and the evolution of senescence. Sci. Aging Knowl. Environ., 2001(1), 2001, cp13.
8. [8] Kirkwood, T.B.L., R. Holiday FRS. The evolution of aging and longevity. Proc. R. Soc. L B Biol. Sci. 205 (1979), 531–546.
9. [9] Kirkwood, T.B.L., Austad, S.N., Why do we age?. Nature 408 (2000), 233–238.
10. [10] Brys, K., Vanfleteren, J.R., Braeckman, B.P., Testing the rate-of-living/oxidative damage theory of aging in the nematode model Caenorhabditis elegans. Exp. Gerontol. 42:9 (2007), 845–851.
11. [11] Colman, R.J., Anderson, R.M., Johnson, S.C., Kastman, E.K., Kosmatka, K.J., Beasley, T.M., et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325:5937 (2009), 201–204.
12. [12] Barzilai, N., Huffman, D.M., Muzumdar, R.H., Bartke, A., The critical role of metabolic pathways in aging. Diabetes 61:6 (2012), 1315–1322.
13. [13] Finkel, T., The metabolic regulation of aging. Nat. Med. 21:12 (2015), 1416–1423.
14. [14] Bjorksten, J., Tenhu, H., The crosslinking theory of aging - added evidence. Exp. Gerontol. 25:2 (1990), 91–95.
15. [15] Gerschman, R., Gilbert, D.L., Nye, S.W., Dwyer, P., Fenn, W.O., Oxygen poisoning and x-irradiation: a mechanism in common. Science 119:3097 (1954), 623–626.
16. [16] Gerschman, R., Gilbert, D.L., Nye, S.W., Fenn, W.O., Influence of x-irradiation on oxygen poisoning in mice. Proc. Soc. Exp. Biol. Med 86:1 (1954), 27–29.
17. [17] Harman, D., Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11:3 (1956), 298–300.
18. [18] Genestra, M., Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal. 19:9 (2007), 1807–1819.
19. [19] Sohal, R.S., Weindruch, R., Oxidative stress, caloric restriction, and aging. Science 273:5271 (1996), 59–63.
20. [20] Sohal, R.S., Orr, W.C., The redox stress hypothesis of aging. Free Radic Biol Med, 52, 2012, Elsevier Inc, 539–555.
21. [21] Beckman, K.B., Ames, B.N., The free radical theory of aging matures. Physiol. Rev. 78:2 (1998), 547–581.
22. [22] Muller, F.L., Lustgarten, M.S., Jang, Y., Richardson, A., Van Remmen, H., Trends in oxidative aging theories. Free Radic. Biol. Med 43:4 (2007), 477–503.
23. [23] Sanz, A., Stefanatos, R.K.A., The mitochondrial free radical theory of aging: a critical view. Curr. Aging Sci. 1:1 (2008), 10–21.
24. [24] Pérez, V.I., Bokov, A., Remmen, H., Mele, J., Van Remmen, H., Mele, J., et al. Is the Oxidative Stress Theory of Aging Dead?. Biochim Biophys. Acta 1790:10 (2009), 1005–1014.
25. [25] Lapointe, J., Hekimi, S., When a theory of aging ages badly. Cell Mol. Life Sci. 67:1 (2010), 1–8.
26. [26] Rugarli, E., Trifunovic, A., Is Mitochondrial Free Radical Theory of Aging Getting Old? Biochim Biophys Acta - Bioenerg, 1847, 2015, Elsevier B.V, 1345–1346.
27. [27] Liu, Y., Long, J., Liu, J., Mitochondrial free radical theory of aging: who moved my premise?. Geriatr. Gerontol. Int 14:4 (2014), 740–749.
28. [28] Barja, G., Updating the mitochondrial free radical theory of aging: an integrated view, key aspects, and confounding concepts. Antioxid. Redox Signal 19:12 (2013), 1420–1445.
29. [29] Barja, G., The mitochondrial free radical theory of aging. (In) Prog. Mol. Biol. Transl. Sci., 2014, 1–27.
30. [30] Jones, D.P., Redox theory of aging. Redox Biol, 5, 2015, Elsevier, 71–79.
31. [31] Hayflick, L., Moorhead, P.S., The serial cultivation of human diploid cell strains. Exp. Cell Res 25 (1961), 585–621.
32. [32] Hayflick, L., The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res 37 (1965), 614–636.
33. [33] Campisi, J., Cancer, aging and cellular senescence. Vivo (Brooklyn) 14:1 (2000), 183–188.
34. [34] Campisi, J., Kim, S.H., Lim, C.S., Rubio, M., Cellular senescence, cancer and aging: the telomere connection. Exp. Gerontol. 36:10 (2001), 1619–1637.
35. [35] Wright, W.E., Shay, J.W., Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr. Opin. Genet Dev. 11:1 (2001), 98–103.
36. [36] Dimri, G.P., What has senescence got to do with cancer?. Cancer Cell. 7:6 (2005), 505–512.
37. [37] Collado, M., Blasco, M. a., Serrano, M., Cellular senescence in cancer and aging. Cell 130:2 (2007), 223–233.
38. [38] Afshari, C. a., Vojta, P.J., Annab, L. a., Futreal, P. a., Willard, T.B., Barrett, J.C., Investigation of the role of G1/S cell cycle mediators in cellular senescence. Exp. Cell Res., 1993, 231–237.
39. [39] Di, A., Steven, L., Kris, P.L., Wahl, G.M., DNA damage triggers a prolonged p53- dependent G arrest ana long-term induction of Cipl in normal human fibroblasts. Genes Dev. 8 (1994), 2540–2551.
40. [40] Ogryzko, V.V., Hirai, T.H., Russanova, V.R., Barbie, D. a., Howard, B.H., Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol. Cell Biol. 16:9 (1996), 5210–5218.
41. [41] Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D., Lowe, S.W., Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16(INK4a). Cell 88:5 (1997), 593–602.
42. [42] Herbig, U., Jobling, W.A., Chen, B.P.C., Chen, D.J., Sedivy, J.M., Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21CIP1, but not p16INK4a. Mol. Cell. 14:4 (2004), 501–513.
43. [43] Zhu, J., Woods, D., McMahon, M., Bishop, J.M., Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:19 (1998), 2997–3007.
44. [44] Olsen, C.L., Gardie, B., Yaswen, P., Stampfer, M.R., Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion. Oncogene 21:41 (2002), 6328–6339.
45. [45] Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444:7119 (2006), 638–642.
46. [46] Wada, T., Joza, N., Cheng, H.M., Sasaki, T., Kozieradzki, I., Bachmaier, K., et al. MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence. Nat. Cell Biol. 6:3 (2004), 215–226.
47. [47] Hewitt, G., Jurk, D., Marques, F.D.M., Correia-Melo, C., Hardy, T., Gackowska, A., et al. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat. Commun. Nat. Publ. Group, a Div. Macmillan Publ. Ltd. All Rights Reserve., 28(3), 2012, 708.
48. [48] Harley, C.B., Futcher, A.B., Greider, C.W., Calvin, H.B., Futcher, A.B., Greider, C.W., Telomeres shorten during ageing of human fibroblasts. Nature 345:6274 (1990), 458–460.
49. [49] Campisi, J., The biology of replicative senescence. Eur. J. Cancer Part A 33:5 (1997), 703–709.
50. [50] Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.P., Morin, G.B., et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279:5349 (1998), 349–352.
51. [51] Lundberg, A.S., Hahn, W.C., Gupta, P., Weinberg, R. a., Genes involved in senescence and immortalization. Curr. Opin. Cell Biol. 12:6 (2000), 705–709.
52. [52] Shawi, M., Autexier, C., Telomerase, senescence and ageing. Mech. Ageing Dev. 129:1–2 (2008), 3–10.
53. [53] von Zglinicki, T., Oxidative stress shortens telomeres. Trends Biochem Sci. 27:7 (2002), 339–344.
54. [54] Zhang, R., Chen, W., Adams, P.D., Molecular dissection of formation of senescence-associated heterochromatin foci. Mol. Cell Biol. 27:6 (2007), 2343–2358.
55. [55] Huschtscha, L.I., Noble, J.R., Neumann, A.A., Moy, E.L., Barry, P., Melki, J.R., et al. Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res. 58:16 (1998), 3508–3512.
56. [56] Itahana, K., Zou, Y., Itahana, Y., Martinez, J.-L., Beausejour, C., Jacobs, J.J.L., et al. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol. Cell Biol. 23:1 (2003), 389–401.
57. [57] Fridlyanskaya, I., Alekseenko, L., Nikolsky, N., Senescence as a general cellular response to stress: a mini-review. Exp. Gerontol. 72 (2015), 124–128.
58. [58] Vijayachandra, K., Lee, J., Glick, A.B., Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model. Cancer Res. 63:13 (2003), 3447–3452.
59. [59] Zhang, H., Cohen, S.N., Smurf2 up-regulation activates telomere-dependent senescence. Genes Dev. 18:24 (2004), 3028–3040.
60. [60] Moiseeva, O., Mallette, F.A., Mukhopadhyay, U.K., Moores, A., Ferbeyre, G., DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation. Mol. Biol. Cell 17:4 (2006), 1583–1592.
61. [61] Courtois-Cox, S., Jones, S.L., Cichowski, K., Many roads lead to oncogene-induced senescence. Oncogene 27:20 (2008), 2801–2809.
62. [62] Gorgoulis, V.G., Halazonetis, T.D., Oncogene-induced senescence: the bright and dark side of the response. Curr. Opin. Cell Biol. 22:6 (2010), 816–827.
63. [63] Hills, S.A., Diffley, J.F.X., DNA replication and oncogene-induced replicative stress. Curr. Biol. 24:10 (2014 19), R435–R444.
64. [64] Aird, K.M., Zhang, R., Nucleotide metabolism, oncogene-induced senescence and cancer. Cancer Lett. 356:2 Pt A (2015), 204–210.
65. [65] Campisi, J., Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120:4 (2005), 513–522.
66. [66] Ewald, J.A., Desotelle, J.A., Wilding, G., Jarrard, D.F., Therapy-induced senescence in cancer. J. Natl. Cancer Inst. 102:20 (2010), 1536–1546.
67. [67] Ramello, M.C., Tosello Boari, J., Canale, F.P., Mena, H.A., Negrotto, S., Gastman, B., et al. Tumor-induced senescent T cells promote the secretion of pro-inflammatory cytokines and angiogenic factors by human monocytes/macrophages through a mechanism that involves Tim-3 and CD40L. Cell Death Dis., 5, 2014, e1507.
68. [68] Young, A.R.J., Narita, M., SASP reflects senescence. EMBO Rep. 10:3 (2009), 228–230.
69. [69] Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.Y., Campisi, J., Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. USA 98:21 (2001), 12072–12077.
70. [70] McCarthy, D. a., Clark, R.R., Bartling, T.R., Trebak, M., Melendez, J.A., Redox-control of the senescence regulator Interleukin-1 α and the secretory phenotype. J. Biol. Chem. 288:45 (2013), 32149–32159.
71. [71] Kuilman, T., Peeper, D.S., Senescence-messaging secretome: sms-ing cellular stress. Nat. Rev. Cancer 9:2 (2009), 81–94.
72. [72] Coppé, J.-P., Desprez, P.-Y., Krtolica, A., Campisi, J., The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev. Pathol. 5 (2010), 99–118.
73. [73] Young, A.R.J., Narita, M., Narita, M., Cell senescence as both a dynamic and a static phenotype. Methods Mol. Biol. 965 (2013), 1–13.
74. [74] Coppé, J.-P., Patil, C.K., Rodier, F., Krtolica, A., Beauséjour, C.M., Parrinello, S., et al. A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. Blagosklonny, M.V., (eds.) PLoS One, 5, 2010, e9188.
75. [75] Acosta, J.C., O'Loghlen, A., Banito, A., Guijarro, M.V., Augert, A., Raguz, S., et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133:6 (2008), 1006–1018.
76. [76] Coppé, J.-P., Patil, C.K., Rodier, F., Sun, Y., Muñoz, D.P., Goldstein, J., et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. Public Libr. Sci. 6:12 (2008), 2853–2868.
77. [77] Salminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M., Soininen, H., Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype. Eur. J. Neurosci. 34:1 (2011), 3–11.
78. [78] Erusalimsky, J.D., Kurz, D.J., Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Exp. Gerontol. 40:8–9 (2005), 634–642.
79. [79] Campisi, J., d'Adda di Fagagna, F., Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8:9 (2007), 729–740.
80. [80] Hoare, M., Narita, M., Transmitting senescence to the cell neighbourhood. Nat. Cell Biol. Nat. Publ. Group 15:8 (2013), 887–889.
81. [81] Nelson, G., Wordsworth, J., Wang, C., Jurk, D., Lawless, C., Martin-Ruiz, C., et al. A senescent cell bystander effect: senescence-induced senescence. Aging Cell. 11:2 (2012), 345–349.
82. [82] Lawless, C., Jurk, D., Gillespie, C.S., Shanley, D., Saretzki, G., von Zglinicki, T., et al. A stochastic step model of replicative senescence explains ROS production rate in ageing cell populations. PLoS One, 7(2), 2012, e32117.
83. [83] Benz, G., Hölzel, D., Schmoeckel, C., Inflammatory cellular infiltrates in melanocytic nevi. Am. J. Derm. 13:6 (1991), 538–542.
84. [84] Xue, W., Zender, L., Miething, C., Dickins, R.A., Hernando, E., Krizhanovsky, V., et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445:7128 (2007 8), 656–660.
85. [85] Krizhanovsky, V., Yon, M., Dickins, R.A., Hearn, S., Simon, J., Miething, C., et al. Senescence of activated stellate cells limits liver fibrosis. Cell 134:4 (2008), 657–667.
86. [86] Kuilman, T., Michaloglou, C., Vredeveld, L.C.W.W., Douma, S., van Doorn, R., Desmet, C.J., et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133:6 (2008), 1019–1031.
87. [87] Wajapeyee, N., Serra, R.W., Zhu, X., Mahalingam, M., Green, M.R., Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132:3 (2008), 363–374.
88. [88] Demaria, M., Ohtani, N., Youssef, S.A., Rodier, F., Toussaint, W., Mitchell, J.R., et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell. 31:6 (2014), 722–733.
89. [89] Jun, J.-I., Lau, L.F., Cellular senescence controls fibrosis in wound healing. Aging (Albany NY) 2:9 (2010), 627–631.
90. [90] Jun, J.-I., Lau, L.F., The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. Nat. Publ. Group 12:7 (2010), 676–685.
91. [91] Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., et al. Programmed cell senescence during mammalian embryonic development. Cell 155:5 (2013), 1104–1118.
92. [92] Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M.C., Di Giacomo, V., et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155:5 (2013), 1119–1130.
93. [93] Meuter, A., Rogmann, L.-M., Winterhoff, B.J., Tchkonia, T., Kirkland, J.L., Morbeck, D.E., Markers of cellular senescence are elevated in murine blastocysts cultured in vitro: molecular consequences of culture in atmospheric oxygen. J. Assist Reprod. Genet 31:10 (2014), 1259–1267.
94. [94] Baker, D.J., Wijshake, T., Tchkonia, T., LeBrasseur, N.K., Childs, B.G., van de Sluis, B., et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nat. Nat. Publ. Group, a Div. Macmillan Publ. Ltd. All Rights Reserve. 479:7372 (2011), 232–236.
95. [95] Byun, H., Lee, Y., Kim, J., From cell senescence to age-related diseases: differential mechanisms of action of senescence-associated secretory phenotypes. BMB Rep. 48:10 (2015), 549–558.
96. [96] Palmer, A.K., Tchkonia, T., LeBrasseur, N.K., Chini, E.N., Xu, M., Kirkland, J.L., Cellular senescence in Type 2 diabetes: a therapeutic opportunity. Diabetes 64:7 (2015), 2289–2298.
97. [97] Burton, D.G.A., Matsubara, H., Ikeda, K., Pathophysiology of vascular calcification: pivotal role of cellular senescence in vascular smooth muscle cells. Exp. Gerontol. 45:11 (2010), 819–824.
98. [98] Freigang, S., Ampenberger, F., Weiss, A., Kanneganti, T.-D., Iwakura, Y., Hersberger, M., et al. Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis. Nat. Immunol. Nat. Publ. Group, a Div. Macmillan Publ. Ltd. All Rights Reserve. 14:10 (2013), 1045–1053.
99. [99] Bhat, R., Crowe, E.P., Bitto, A., Moh, M., Katsetos, C.D., Garcia, F.U., et al. Astrocyte senescence as a component of Alzheimer's disease. PLoS One, 7(9), 2012, e45069.
100. [100] Chinta, S.J., Woods, G., Rane, A., Demaria, M., Campisi, J., Andersen, J.K., Cellular senescence and the aging brain. Exp. Gerontol. 68 (2015), 3–7.
101. [101] Kumar, M., Seeger, W., Voswinckel, R., Senescence-associated secretory phenotype and its possible role in chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. Am. Thorac. Soc. 51:3 (2014), 323–333.
102. [102] Meng, L., Quezada, M., Levine, P., Han, Y., McDaniel, K., Zhou, T., et al. Functional role of cellular senescence in biliary injury. Am. J. Pathol. 185:3 (2015), 602–609.
103. [103] Benderdour, M., Martel-Pelletier, J., Pelletier, J.-P., Kapoor, M., Zunzunegui, M.-V., Fahmi, H., Cellular Aging, Senescence and Autophagy Processes in Osteoarthritis. Curr. Aging Sci., 8, 2015, Bentham Science Publishers, 147–157.
104. [104] Campisi, J., Andersen, J.K., Kapahi, P., Melov, S., Cellular senescence: A link between cancer and age-related degenerative disease? Semin. Cancer Biol., 21, 2011, Elsevier Ltd, 354–359.
105. [105] Coppé, J.-P., Desprez, P.-Y., Krtolica, A., Campisi, J., The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev. Pathol. 5 (2010), 99–118.
106. [106] Laberge, R.-M., Awad, P., Campisi, J., Desprez, P.-Y., Epithelial-mesenchymal transition induced by senescent fibroblasts. Cancer Microenviron. 5:1 (2012), 39–44.
107. [107] Bedi, S., Vidyasagar, A., Djamali, A., Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transpl. Rev. 22:1 (2008), 1–5.
108. [108] Scharl, M., Huber, N., Lang, S., Fürst, A., Jehle, E., Rogler, G., Hallmarks of epithelial to mesenchymal transition are detectable in Crohn's disease associated intestinal fibrosis. Clin. Transl. Med, 4, 2015, 1.
109. [109] Canaud, G., Bonventre, J.V., Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury. Nephrol. Dial Transplant, 30, 2015, Oxford University Press, 575–583.
110. [110] Ferenbach, D.A., Bonventre, J.V., Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat Rev Nephrol. Nat. Publ. Group, a Div. Macmillan Publ. Ltd. All Rights Reserve. 11:5 (2015), 264–276.
111. [111] Wullschleger, S., Loewith, R., Hall, M.N., TOR signaling in growth and metabolism. Cell 124:3 (2006), 471–484.
112. [112] Xu, S., Cai, Y., Wei, Y., mTOR signaling from cellular senescence to organismal. Aging Aging Dis. 5:4 (2014), 263–273.
113. [113] Hay, N., Sonenberg, N., Upstream and downstream of mTOR. Genes Dev. 18:16 (2004), 1926–1945.
114. [114] Zoncu, R., Efeyan, A., Sabatini, D.M., mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12:1 (2011), 21–35.
115. [115] Chung, K.W., Kim, D.H., Park, M.H., Choi, Y.J., Kim, N.D., Lee, J., et al. Recent advances in calorie restriction research on aging. Exp. Gerontol. 48:10 (2013), 1049–1053.
116. [116] Dulic, V., Senescence regulation by mTOR. (Clifton, N.J.) Methods Mol. Biol., 2013, 15–35.
117. [117] Sarbassov, D.D., Sabatini, D.M., Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex. J. Biol. Chem. 280:47 (2005), 39505–39509.
118. [118] Yoshida, S., Hong, S., Suzuki, T., Nada, S., Mannan, A.M., Wang, J., et al. Redox regulates mammalian target of rapamycin complex 1 (mTORC1) activity by modulating the TSC1/TSC2-Rheb GTPase pathway. J Biol Chem. American Society for. Biochem. Mol. Biol. 286:37 (2011 16), 32651–32660.
119. [119] Ramírez-Rangel, I., Bracho-Valdés, I., Vázquez-Macías, A., Carretero-Ortega, J., Reyes-Cruz, G., Vázquez-Prado, J., Regulation of mTORC1 complex assembly and signaling by GRp58/ERp57. Mol Cell Biol, 31, 2011, American Society for Microbiology (ASM), 1657–1671.
120. [120] Liu, L., Wise, D.R., Diehl, J.A., Simon, M.C., Hypoxic reactive oxygen species regulate the integrated stress response and cell survival. J. Biol Chem. Am. Soc. Biochem. Mol. Biol. 283:45 (2008), 31153–31162.
121. [121] Nayak, B.K., Feliers, D., Sudarshan, S., Friedrichs, W.E., Day, R.T., New, D.D., et al. Stabilization of HIF-2α through redox regulation of mTORC2 activation and initiation of mRNA translation. Oncogene. NIH Public Access 32:26 (2013), 3147–3155.
122. [122] Kaeberlein M, Kennedy BK. Hot topics in aging research: Protein translation and TOR signaling, 2010. Aging Cell. 2011 Apr;10(2):185–190.
123. [123] Rider, P., Carmi, Y., Voronov, E., Apte, R.N., Interleukin-1α. Semin. Immunol. 25:6 (2013), 430–438.
124. [124] Kobayashi, Y., Yamamoto, K., Saido, T., Kawasaki, H., Oppenheim, J.J., Matsushima, K., Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha. Proc. Natl. Acad. Sci. USA 87:14 (1990), 5548–5552.
125. [125] Afonina, I.S., Tynan, G. a., Logue, S.E., Cullen, S.P., Bots, M., Lüthi, A.U., et al. Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α. Mol. Cell 44:2 (2011), 265–278.
126. [126] Melendez, J.A., Davies, K.J., Manganese superoxide dismutase modulates interleukin-1alpha levels in HT-1080 fibrosarcoma cells. J. Biol. Chem. 271:31 (1996), 18898–18903.
127. [127] Moerman-Herzog, A.M., Barger, S.W., A polymorphism in the upstream regulatory region of the interleukin-1α gene confers differential binding by transcription factors of the AP-1 family. Life Sci. 90:25–26 (2012), 975–979.
128. [128] Dasgupta, J., Kar, S., Liu, R., Joseph, J., Kalyanaraman, B., Remington, S.J., et al. Reactive oxygen species control senescence-associated matrix metalloproteinase-1 through c-Jun-N-terminal kinase. J. Cell Physiol. 225:1 (2010), 52–62.
129. [129] McCarthy, D. a., Ranganathan, A., Subbaram, S., Flaherty, N.L., Patel, N., Trebak, M., et al. Redox-control of the alarmin, Interleukin-1α. Redox Biol. 1:1 (2013), 218–225.
130. [130] Laberge, R.-M., Sun, Y., Orjalo, A.V., Patil, C.K., Freund, A., Zhou, L., et al. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol. Nat. Publ. Group 17:8 (2015), 1049–1061.
131. [131] Pardo, A., Selman, M., MMP-1: the elder of the family. Int J. Biochem Cell Biol. 37:2 (2005), 283–288.
132. [132] Kar, S., Subbaram, S., Carrico, P.M., Melendez, J.A., Redox-control of matrix metalloproteinase-1: a critical link between free radicals, matrix remodeling and degenerative disease. Respir. Physiol. Neurobiol., 174, 2010, Elsevier B.V, 299–306.
133. [133] Lu, Y., Wahl, L.M., Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF- κB activity in lipopolysaccharide-activated human primary monocytes. J. Immunol. 175 (2005), 5423–5429.
134. [134] Nelson, K.K., Melendez, J.A., Mitochondrial redox control of matrix metalloproteinases. Free Radic. Biol. Med 37:6 (2004), 768–784.
135. [135] Touyz, R.M., Mitochondrial redox control of matrix metalloproteinase signaling in resistance arteries. Arterioscler Thromb. Vasc. Biol. 26:4 (2006), 685–688.
136. [136] Prado, A., Pernomian, L., Azevedo, A., Castro, M., Bendhack, L., Tanus-Santos, J., et al. Matrix metalloproteinase 2 increases ROS in aortic tissue (1153.10). FASEB J., 2014 (Apr;28(1_Supplement)(:1153.10-).
137. [137] Brkic, M., Balusu, S., Libert, C., Vandenbroucke, R.E., Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases. Mediat. Inflamm., 2015, 2015, 620581.
138. [138] Fisher, G.J., Quan, T., Purohit, T., Shao, Y., Cho, M.K., He, T., et al. Collagen fragmentation promotes oxidative stress and elevates matrix metalloproteinase-1 in fibroblasts in aged human skin. Am. J. Pathol. 174:1 (2009), 101–114.
139. [139] Wenk, J., Brenneisen, P., Wlaschek, M., Poswig, A., Briviba, K., Oberley, T.D., et al. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J. Biol. Chem. 274:36 (1999), 25869–25876.
140. [140] Zaw KK, Yokoyama Y, Abe M, Ishikawa O. Catalase restores the altered mRNA expression of collagen and matrix metalloproteinases by dermal fibroblasts exposed to reactive oxygen species. Eur J Dermatol. Jan;16(4):375–379.
141. [141] Orbe, J., Rodríguez, J.A., Arias, R., Belzunce, M., Nespereira, B., Pérez-Ilzarbe, M., et al. Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: implications for plaque stabilization. Atherosclerosis 167:1 (2003), 45–53.
142. [142] Fisher, G.J., Talwar, H.S., Lin, J., Voorhees, J.J., Molecular mechanisms of photoaging in human skin in vivo and their prevention by all-trans retinoic acid. Photochem. Photobiol. 69:2 (1999), 154–157.
143. [143] Lee, B., Moon, S.-K., Resveratrol inhibits TNF-alpha-induced proliferation and matrix metalloproteinase expression in human vascular smooth muscle cells. J. Nutr. 135:12 (2005), 2767–2773.
144. [144] Hozumi, A., Nishimura, Y., Nishiuma, T., Kotani, Y., Yokoyama, M., Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 281:6 (2001), L1444–L1452.
145. [145] Ranganathan, A.C., Nelson, K.K., Rodriguez, A.M., Kim, K.H., Tower, G.B., Rutter, J.L., et al. Manganese superoxide dismutase signals matrix metalloproteinase expression via H2O2-dependent ERK1/2 activation. J. Biol. Chem. 276:17 (2001), 14264–14270.
146. [146] Warner, R.L., Bless, N.M., Lewis, C.S., Younkin, E., Beltran, L., Guo, R., et al. Time-dependent inhibition of immune complex-induced lung injury by catalase: relationship to alterations in macrophage and neutrophil matrix metalloproteinase elaboration. Free Radic. Biol. Med. 29:1 (2000), 8–16.
147. [147] Toth, P., Tarantini, S., Springo, Z., Tucsek, Z., Gautam, T., Giles, C.B., et al. Aging exacerbates hypertension-induced cerebral microhemorrhages in mice: role of resveratrol treatment in vasoprotection. Aging Cell. Wiley-Black. 14:3 (2015), 400–408.
148. [148] Barbieri, M., Bonafè, M., Franceschi, C., Paolisso, G., Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am. J. Physiol. Endocrinol. Metab. 285:5 (2003), E1064–E1071.
149. [149] Kenyon, C., The first long-lived mutants: discovery of the insulin/IGF-1 pathway for ageing. Philos Trans. R. Soc. Lond. B Biol. Sci. 366:1561 (2011), 9–16.
150. [150] Murakami, S., Salmon, A., Miller, R.A., Multiplex stress resistance in cells from long-lived dwarf mice. FASEB J. 17:11 (2003), 1565–1566.
151. [151] Richardson, A., Liu, F., Adamo, M.L., Van Remmen, H., Nelson, J.F., The role of insulin and insulin-like growth factor-I in mammalian ageing. Best. Pr. Res Clin. Endocrinol. Metab. 18:3 (2004), 393–406.
152. [152] van der Horst, A., Burgering, B.M.T., Stressing the role of FoxO proteins in lifespan and disease. Nat. Rev. Mol. Cell Biol. 8:6 (2007), 440–450.
153. [153] Martins, R., Lithgow, G.J., Link, W., Long live FOXO: unraveling the role of FOXO proteins in aging and longevity. Aging Cell., 2015, 8.
154. [154] Vurusaner, B., Poli, G., Basaga, H., Tumor suppressor genes and ROS: Complex networks of interactions. Free Radic. Biol. Med., 52, 2012, Elsevier Inc, 7–18.
155. [155] GJPL, Kops, Dansen, T.B., Polderman, P.E., Saarloos, I., KWA, Wirtz, Coffer, P.J., et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419:6904 (2002), 316–321.
156. [156] Chiribau, C.B., Cheng, L., Cucoranu, I.C., Yu, Y.-S., Clempus, R.E., Sorescu, D., FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts. J. Biol. Chem. 283:13 (2008), 8211–8217.
157. [157] Honda, Y., Tanaka, M., Honda, S., Redox regulation, gene expression and longevity. Geriatr. Gerontol. Int 10:Suppl 1 (2010), S59–S69.
158. [158] Dansen, T.B., Smits, L.M.M., Van, Triest M.H., De, Keizer P.L.J., Van, Leenen D., Koerkamp, M.G., et al. Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity. Nat. Chem. Biol. 5:9 (2009), 664–672.
159. [159] Kim, K.S., Kim, M.-S., Seu, Y.B., Chung, H.Y., Kim, J.H., Kim, J.-R., Regulation of replicative senescence by insulin-like growth factor-binding protein 3 in human umbilical vein endothelial cells. Aging Cell. 6:4 (2007), 535–545.
160. [160] Kim, K.S., Seu, Y.B., Baek, S.-H., Kim, M.J., Kim, K.J., Kim, J.H., et al. Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Mol. Biol. Cell 18:11 (2007), 4543–4552.
161. [161] Severino, V., Alessio, N., Farina, A., Sandomenico, A., Cipollaro, M., Peluso, G., et al. Insulin-like growth factor binding proteins 4 and 7 released by senescent cells promote premature senescence in mesenchymal stem cells. Cell Death Dis., 4, 2013, e911.
162. [162] López-Bermejo, A., Buckway, C.K., Devi, G.R., Hwa, V., Plymate, S.R., Oh, Y., et al. Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium. Endocrinology 141:11 (2000), 4072–4080.
163. [163] Kim, K.-H., Park, G.-T., Lim, Y.-B., Rue, S.-W., Jung, J.-C., Sonn, J.-K., et al. Expression of connective tissue growth factor, a biomarker in senescence of human diploid fibroblasts, is up-regulated by a transforming growth factor-beta-mediated signaling pathway. Biochem Biophys. Res Commun. 318:4 (2004), 819–825.
164. [164] Zuo, S., Liu, C., Wang, J., Wang, F., Xu, W., Cui, S., et al. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells. J. Cancer Res Clin. Oncol. 138:6 (2012), 1045–1055.
165. [165] Courtois-Cox, S., Genther Williams, S.M., Reczek, E.E., Johnson, B.W., McGillicuddy, L.T., Johannessen, C.M., et al. A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell. 10:6 (2006), 459–472.
166. [166] Dröge, W., Oxidative aging and insulin receptor signaling. J. Gerontol. Ser. A Biol. Sci. Med Sci. 60:11 (2005), 1378–1385.
167. [167] Mahadev, K., Zilbering, A., Zhu, L., Goldstein, B.J., Insulin-stimulated Hydrogen Peroxide Reversibly Inhibits Protein-tyrosine Phosphatase 1B in Vivo and Enhances the Early Insulin Action Cascade. J. Biol. Chem. 276:24 (2001), 21938–21942.
168. [168] Goldstein, B.J., Mahadev, K., Wu, X., Zhu, L., Motoshima, H., Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxid. Redox Signal 7:7–8 (2005), 1021–1031.
169. [169] Rincon, M., Muzumdar, R., Atzmon, G., Barzilai, N., The paradox of the insulin/IGF-1 signaling pathway in longevity. Mech. Ageing Dev. 125:6 (2004), 397–403.
170. [170] Salminen, A., Kaarniranta, K., Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-kappaB signaling. Cell Signal. 22:4 (2010), 573–577.
171. [171] Berridge, M., Lipp, P., Bootman, M., The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell 1 (2000), 11–21.
172. [172] Ureshino, R.P., Rocha, K.K., Lopes, G.S., Bincoletto, C., Smaili, S.S., Calcium signaling alterations, oxidative stress, and autophagy in aging. Antioxid. Redox Signal 21:1 (2014), 123–137.
173. [173] Farfariello, V., Iamshanova, O., Germain, E., Fliniaux, I., Prevarskaya, N., Calcium homeostasis in cancer: A focus on senescence. Biochim. Biophys. Acta - Mol. Cell Res, 1853, 2014, Elsevier B.V, 1974–1979.
174. [174] Lang, F., Busch, G.L., Ritter, M., Völkl, H., Waldegger, S., Gulbins, E., et al. Functional significance of cell volume regulatory mechanisms. Physiol. Rev. 78:1 (1998), 247–306.
175. [175] Becker, D., Blase, C., Bereiter-Hahn, J., Jendrach, M., TRPV4 exhibits a functional role in cell-volume regulation. J. Cell Sci. 118:Pt 11 (2005), 2435–2440.
176. [176] Numata, T., Shimizu, T., Okada, Y., Direct mechano-stress sensitivity of TRPM7 channel. Cell Physiol. Biochem., 19, 2007, Karger Publishers, 1–8.
177. +/NADH metabolism, protein acetylation, and sirtuin expression. Mol. Cell Biol. 34:15 (2014), 2890–2902.
178. [178] Wiel, C., Lallet-Daher, H., Gitenay, D., Gras, B., Le Calvé, B., Augert, A., et al. Endoplasmic reticulum calcium release through ITPR2 channels leads to mitochondrial calcium accumulation and senescence. Nat. Commun. 5 (2014), 3792–3793.
179. [179] Arnould, T., Vankoningsloo, S., Renard, P., Houbion, A., Ninane, N., Demazy, C., et al. CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation. EMBO J, 21, 2002, 53–63.
180. [180] Sharov, V.S., Dremina, E.S., Galeva, N.A., Williams, T.D., Schöneich, C., Quantitative mapping of oxidation-sensitive cysteine residues in SERCA in vivo and in vitro by HPLC–electrospray-tandem MS: selective protein oxidation during biological aging, 394, 2006, Biochem J. Portland Press Ltd, 605.
181. [181] Qin, F., Siwik, D.A., Lancel, S., Zhang, J., Kuster, G.M., Luptak, I., et al. Hydrogen peroxide-mediated SERCA cysteine 674 oxidation contributes to impaired cardiac myocyte relaxation in senescent mouse heart. J. Am. Heart Assoc. Wiley-Black., 2(4), 2013, e000184.
182. [182] Blander, G., Guarente, L., The Sir2 family of protein deacetylases. Annu Rev. Biochem 73 (2004), 417–435.
183. [183] Vaziri, H., Dessain, S.K., Eaton, E.N., Imai, S.-I., Frye, R.A., Pandita, T.K., et al. hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase. Cell 107:2 (2001), 149–159.
184. [184] Mahlknecht, U., Ho, A.D., Voelter-Mahlknecht, S., Chromosomal organization and fluorescence in situ hybridization of the human Sirtuin 6 gene. Int J. Oncol. 28:2 (2006), 447–456.
185. [185] Ford, E., Voit, R., Liszt, G., Magin, C., Grummt, I., Guarente, L., Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 20:9 (2006), 1075–1080.
186. [186] North, B.J., Marshall, B.L., Borra, M.T., Denu, J.M., Verdin, E., The Human Sir2 Ortholog, SIRT2, Is an NAD+-Dependent Tubulin Deacetylase. Mol. Cell. 11:2 (2003), 437–444.
187. [187] Michan, S., Sinclair, D., Sirtuins in mammals: insights into their biological function. Biochem J. Portland Press Ltd. 404:1 (2007), 1–13.
188. [188] Lin, S.-J., Ford, E., Haigis, M., Liszt, G., Guarente, L., Calorie restriction extends yeast life span by lowering the level of NADH. Genes Dev. 18:1 (2004), 12–16.
189. [189] Rodgers, J.T., Lerin, C., Haas, W., Gygi, S.P., Spiegelman, B.M., Puigserver, P., Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nat. Nat. Publ. Group 434:7029 (2005), 113–118.
190. [190] Zhang, Q., Wang, S.-Y., Fleuriel, C., Leprince, D., Rocheleau, J.V., Piston, D.W., et al. Metabolic regulation of SIRT1 transcription via a HIC1: ctbp corepressor complex. Proc. Natl. Acad. Sci. USA 104:3 (2007), 829–833.
191. [191] Prozorovski, T., Schulze-Topphoff, U., Glumm, R., Baumgart, J., Schröter, F., Ninnemann, O., et al. Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nat. Cell Biol. Nat. Publ. Group 10:4 (2008), 385–394.
192. [192] Chen, R., Dioum, E.M., Hogg, R.T., Gerard, R.D., Garcia, J.A., Hypoxia increases sirtuin 1 expression in a hypoxia-inducible factor-dependent manner. J. Biol. Chem. 286:16 (2011), 13869–13878.
193. [193] Kume, S., Haneda, M., Kanasaki, K., Sugimoto, T., Araki, S., Isono, M., et al. Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation. Free Radic. Biol. Med 40:12 (2006), 2175–2182.
194. [194] Furukawa, A., Tada-Oikawa, S., Kawanishi, S., Oikawa, S., H2O2 accelerates cellular senescence by accumulation of acetylated p53 via decrease in the function of SIRT1 by NAD+ depletion. Cell Physiol. Biochem. 20:1–4 (2007), 45–54.
195. [195] Tanno, M., Kuno, A., Yano, T., Miura, T., Hisahara, S., Ishikawa, S., et al. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J. Biol. Chem. 285:11 (2010), 8375–8382.
196. [196] Volonte, D., Zou, H., Bartholomew, J.N., Liu, Z., Morel, P.A., Galbiati, F., Oxidative stress-induced inhibition of Sirt1 by caveolin-1 promotes p53-dependent premature senescence and stimulates the secretion of interleukin 6 (IL-6). J. Biol. Chem. 290:7 (2015), 4202–4214.
197. [197] Yeung, F., Hoberg, J.E., Ramsey, C.S., Keller, M.D., Jones, D.R., Frye, R.A., et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. EMBO Press 23:12 (2004), 2369–2380.
198. [198] Yang, S.-R., Wright, J., Bauter, M., Seweryniak, K., Kode, A., Rahman, I., Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am. J. Physiol. Lung Cell Mol. Physiol. 292:2 (2007), L567–L576.
199. [199] Rajendrasozhan, S., Yang, S.-R., Kinnula, V.L., Rahman, I., SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177:8 (2008), 861–870.
200. [200] Kume, S., Uzu, T., Horiike, K., Chin-Kanasaki, M., Isshiki, K., Araki, S.-I., et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J. Clin. Invest. Am. Soc. Clin. Investig. 120:4 (2010), 1043–1055.
201. [201] Brunet, A., Sweeney, L.B., Sturgill, J.F., Chua, K.F., Greer, P.L., Lin, Y., et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303:5666 (2004), 2011–2015.
202. [202] Hong, E.-H., Lee, S.-J., Kim, J.-H.J.-I.J.-S., Lee, K.-H., Um, H.-D., Kim, J.-H.J.-I.J.-S., et al. Ionizing radiation induces cellular senescence of articular chondrocytes via negative regulation of SIRT1 by p38 kinase. J. Biol. Chem. Am. Soc. Biochem. Mol. Biol. 285:2 (2010), 1283–1295.
203. [203] Li, Y., Xu, W., McBurney, M.W., Longo, V.D., SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metab. 8:1 (2008), 38–48.
204. [204] Tran, D., Bergholz, J., Zhang, H., He, H., Wang, Y., Zhang, Y., et al. Insulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence. Aging Cell. 13:4 (2014), 669–678.
205. [205] Hayakawa, T., Iwai, M., Aoki, S., Takimoto, K., Maruyama, M., Maruyama, W., et al. SIRT1 suppresses the senescence-associated secretory phenotype through epigenetic gene regulation. PLoS One, 10(1), 2015, e0116480.
206. [206] Qiu, X., Brown, K., Hirschey, M.D., Verdin, E., Chen, D., Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab., 12, 2010, Elsevier Inc, 662–667.
207. [207] Tao, R., Coleman, M.C., Pennington, J.D., Ozden, O., Park, S.H., Jiang, H., et al. Sirt3-Mediated Deacetylation of Evolutionarily Conserved Lysine 122 Regulates MnSOD Activity in Response to Stress. Mol Cell, 40, 2010, Elsevier Inc, 893–904.
208. [208] Bell, E.L., Emerling, B.M., Ricoult, S.J.H., Guarente, L., SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production. Oncogene. Macmillan Publ. Ltd. 30:26 (2011), 2986–2996.
209. [209] Someya, S., Yu, W., Hallows, W.C., Xu, J., Vann, J.M., Leeuwenburgh, C., et al. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143:5 (2010), 802–812.
210. [210] Chen, Y., Zhang, J., Lin, Y., Lei, Q., Guan, K.-L., Zhao, S., et al. Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep. 12:6 (2011), 534–541.
211. [211] Bao, J., Scott, I., Lu, Z., Pang, L., Dimond, C.C., Sack, M.N., SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicity. Free Radic. Biol. Med 49:7 (2011), 1230–1237.
212. [212] McDonnell, E., Peterson, B.S., Bomze, H.M., Hirschey, M.D., SIRT3 regulates progression and development of diseases of aging. Trends Endocrinol. Metab. 26:9 (2015), 486–492.
213. [213] Liao, C.-Y., Kennedy, B.K., SIRT6, oxidative stress, and aging. Cell Res, 2016, Nature Publishing Group, 1–2.
214. [214] Ghosh, S., Zhou, Z., SIRTain regulators of premature senescence and accelerated aging. Protein Cell. 6:5 (2015), 322–333.
215. [215] Meter, M., Van, Mao, Z., Gorbunova, V., Seluanov, A., SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells. Cell Cycle Taylor Fr., 2011, 15.
216. [216] Pan, H., Guan, D., Liu, X., Li, J., Wang, L., Wu, J., et al. SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2. Nat. Publ. Gr. Nat. Publ. Group 26:2 (2016), 190–205.
217. [217] Wątroba, M., Szukiewicz, D., The role of sirtuins in aging and age-related diseases. Adv. Med Sci. 61:1 (2015), 52–62.
218. [218] Blackburn, E.H., Epel, E.S., Lin, J., Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Science 350:6265 (2015), 1193–1198.
219. [219] Rodier, F., Muñoz, D.P., Teachenor, R., Chu, V., Le, O., Bhaumik, D., et al. DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J. Cell Sci. 124:Pt 1 (2011), 68–81.
220. [220] Toussaint, O., Medrano, E.E., von Zglinicki, T., Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp. Gerontol. 35:8 (2000), 927–945.
221. [221] Chen, Q.M., Prowse, K.R., Tu, V.C., Purdom, S., Linskens, M.H., Uncoupling the senescent phenotype from telomere shortening in hydrogen peroxide-treated fibroblasts. Exp. Cell Res 265:2 (2001), 294–303.
222. [222] Kawanishi, S., Oikawa, S., Mechanism of telomere shortening by oxidative stress. Ann. N. Y Acad. Sci. 1019 (2004), 278–284.
223. [223] Tsolou, A., Passos, J.F., Nelson, G., Arai, Y., Zglinicki, T. von, ssDNA fragments induce cell senescence by telomere uncapping. Exp. Gerontol. 43:10 (2008), 892–899.
224. [224] Richter, T., Saretzki, G., Nelson, G., Melcher, M., Olijslagers, S., von Zglinicki, T., TRF2 overexpression diminishes repair of telomeric single-strand breaks and accelerates telomere shortening in human fibroblasts. Mech. Ageing Dev. 128:4 (2007), 340–345.
225. [225] Karlseder, J., Hoke, K., Mirzoeva, O.K., Bakkenist, C., Kastan, M.B., Petrini, J.H.J., et al. The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response. PLoS Biol., 2(8), 2004, E240.
226. [226] Fotiadou, P., Henegariu, O., Sweasy, J.B., DNA polymerase beta interacts with TRF2 and induces telomere dysfunction in a murine mammary cell line. Cancer Res. 64:11 (2004), 3830–3837.
227. [227] Criscione, S.W., De Cecco, M., Siranosian, B., Zhang, Y., Kreiling, J.A., Sedicy, J.M., et al. Reorganization of chromosome architecture in replicative cellular senescence. Sci. Adv. 2:2 (2016), 1–12.
228. [228] Proctor, C.J., Kirkwood, T.B.L., Modelling telomere shortening and the role of oxidative stress. Mech. Ageing Dev. 123:4 (2002), 351–363.
229. [229] Op Den, Buijs J., Van Den Bosch, P.P.J., Musters, M.W.J.M., Van Riel, N. a.W., Mathematical modeling confirms the length-dependency of telomere shortening. Mech. Ageing Dev. 125:6 (2004), 437–444.
230. [230] Mendelsohn, A.R., Larrick, J.W., Ectopic expression of telomerase safely increases health span and life span. Rejuvenation Res. 15:4 (2012), 435–438.
231. [231] Kiyono, T., Foster, S.A., Koop, J.I., McDougall, J.K., Galloway, D.A., Klingelhutz, A.J., Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396:6706 (1998), 84–88.
232. [232] Simons, M.J.P., Questioning causal involvement of telomeres in aging. Ageing Res Rev, 24, 2015, Elsevier B.V, 6–11.
233. [233] Mombach, J.C.M., Bugs, C.A., Chaouiya, C., Modelling the onset of senescence at the G1/S cell cycle checkpoint. BMC Genom. BioMed. Cent., 2014, 15 (Suppl 7(7)(:S7).
234. [234] Chen, J., Huang, X., Halicka, D., Brodsky, S., Avram, A., Eskander, J., et al. Contribution of p16INK4a and p21CIP1 pathways to induction of premature senescence of human endothelial cells: permissive role of p53. Am. J. Physiol. Heart Circ. Physiol. 290:4 (2006), H1575–H1586.
235. [235] Chandler, H., Peters, G., Stressing the cell cycle in senescence and aging. Curr. Opin. Cell Biol. 25:6 (2013), 765–771.
236. [236] Takeuchi, S., Takahashi, A., Motoi, N., Yoshimoto, S., Tajima, T., Yamakoshi, K., et al. Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo. Cancer Res. 70:22 (2010), 9381–9390.
237. [237] Yamakoshi, K., Takahashi, A., Hirota, F., Nakayama, R., Ishimaru, N., Kubo, Y., et al. Real-time in vivo imaging of p16Ink4a reveals cross talk with p53. J. Cell Biol. 186:3 (2009), 393–407.
238. [238] Adams, P.D., Healing and Hurting: Molecular Mechanisms, Functions, and Pathologies of Cellular Senescence. Mol Cell, 36, 2009, Elsevier Inc, 2–14.
239. [239] Rayess, H., Wang, M.B., Srivatsan, E.S., Cellular senescence and tumor suppressor gene p16. Int J. Cancer 130:8 (2012), 1715–1725.
240. [240] Campisi, J., Aging, cellular senescence, and cancer. Annu Rev. Physiol. 75 (2013), 685–705.
241. [241] Rodier, F., Coppé, J.-P., Patil, C.K., Hoeijmakers, W.A.M., Muñoz, D.P., Raza, S.R., et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 11:8 (2009), 973–979.
242. [242] Muñoz-Espín, D., Serrano, M., Cellular senescence: from physiology to pathology. Nat Rev Mol Cell Biol. Nat. Publ. Group 15:7 (2014), 482–496.
243. [243] Demidenko, Z.N., Korotchkina, L.G., Gudkov, A.V., Blagosklonny, M.V., Paradoxical suppression of cellular senescence by p53. Proc. Natl. Acad. Sci. USA 107:21 (2010), 9660–9664.
244. [244] Vigneron, A., Vousden, K.H., p53, ROS and senescence in the control of aging. Aging (Albany NY) 2:8 (2010), 471–474.
245. [245] Wei, Z., Guo, H., Liu, Z., Zhang, X., Liu, Q., Qian, Y., et al. CUL4B impedes stress-induced cellular senescence by dampening a p53-reactive oxygen species positive feedback loop. Free Radic. Biol. Med 79 (2015), 1–13.
246. [246] Volonte, D., Zou, H., Bartholomew, J.N., Liu, Z., Morel, P.A., Galbiati, F., Oxidative stress-induced inhibition of Sirt1 by caveolin-1 promotes p53-dependent premature senescence and stimulates the secretion of interleukin 6 (IL-6). J. Biol. Chem. Am. Soc. Biochem. Mol. Biol. 290:7 (2015), 4202–4214.
247. [247] Kim, J.-E., Shin, J.-S., Moon, J.-H., Hong, S.-W., Jung, D.-J., Kim, J.H., et al. Foxp3 is a key downstream regulator of p53-mediated cellular senescence. Oncogene, 30, 2016, Nature Publishing Group, 1–12.
248. [248] Probin, V., Wang, Y., Zhou, D., Busulfan-induced senescence is dependent on ROS production upstream of the MAPK pathway. Free Radic. Biol. Med. NIH Public Access 42:12 (2007), 1858–1865.
249. [249] Zhang, Y., Zhang, Y., Zhong, C., Xiao, F., Barceloux, D.G., Hayflick, L., et al. Cr(VI) induces premature senescence through ROS-mediated p53 pathway in L-02 hepatocytes. Sci. Rep., 4, 2016, Nature Publishing Group, 34578.